Intrinsic Value of S&P & Nasdaq Contact Us

Glaukos Corporation GKOS NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$143.44
+19%

Glaukos Corporation (GKOS) has a consensus analyst rating of Buy, based on 24 analysts covering the stock. Of those, 18 recommend buying, 5 recommend holding, and 1 recommend selling.

The analyst consensus price target for GKOS is $143.44, representing a +19.0% upside from the current price of $120.52. Price targets range from a low of $127.00 to a high of $165.00.

Analyst Consensus — GKOS

Buy
Strong Buy
0
Buy
18
Hold
5
Sell
1
Strong Sell
0
24 analysts
Price Targets
Consensus$143.44
High$165.00
Low$127.00
Median$145.00
Last Month Avg-
Last Quarter Avg$142.67
Last Year Avg$129.27
All-Time Count42
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message